Reasons Lilly Stock Like There’s No Tomorrow: A Bold Buy
Seeking a stock with growth, resilience, and optionality? This article lays out three strong reasons to consider Lill...
Biotech Stocks
Biotech Stocks page aggregates 6 articles covering catalysts, earnings moves, and company updates to help you spot opportunities and manage biotech investments more confidently.
158 articles
What Does Bicara Therapeutics CEO Sale Signal Investors
When a biotech CEO sells shares after exercising options, investors rightly pause to interpret the move. This article...
Precigen (PGEN) Stock Sell: Should You Dump After CFO Sale?
A recent insider move at Precigen has many investors asking if a CFO’s share sale signals trouble. This deep-dive bre...
Johnson Johnson Just Paid a $1B Bet on Undruggable Target
When a global pharma giant drops $1 billion on a single tech, investors sit up. This move by Johnson Johnson Just Pai...
Lexicon Pharmaceuticals Pfizer: Which Stock Is Best Buy 2026
In 2026, investors face a choice between a nimble biotech player and a global pharma titan. This guide compares Lexic...
Wall Street Analyst Thinks Viking Stock Could Soar 188%
A wall street analyst thinks Viking Therapeutics could unlock substantial upside if VK2735 delivers in Phase 3. Learn...
Does Moderna Need Start Profits? Investor Guide Today
Moderna rose to fame with COVID-19 vaccines, but the road to sustained profits is more complex. This guide breaks dow...
CEO Sells Shares Biotech Stock: Understanding Insider Moves
When a biotech company’s leader sells shares, it can raise questions for investors. This guide breaks down how to int...
Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Here's Grail Stock Soared: What Drove the May Rally and Where It's Heading
In May, Grail stock surged on optimism about FDA approval timing and potential reimbursement for the Galleri MCED tes...
Revolution Medicines This Year: Bulls and Bears for RVMD
Investors are buzzing about Revolution Medicines this year as its RAS-focused cancer programs advance. This article l...
MoonLake Immunotherapeutics Trims Stake: Investor Watch
When a high-level insider trims a stake, it can spark questions about a company’s near-term prospects. This article b...
Related Topics
#Investing (126)
#Stock Analysis (39)
#Earnings Analysis (28)
#Insider Trading (22)
#Stock Market (16)
#Stock Market News (16)
#Earnings (14)
#Portfolio Strategy (12)
#Portfolio Management (11)
#Investing Strategy (9)
#SEC Filings (7)
#risk-management (6)
#Hedge Funds (6)
#CRISPR (6)
#Pharmaceuticals (5)